Eosinophilic inflammation assessed by induced sputum in corticosteroid-dependent asthma

Respiratory Medicine

Volumn 93, Issue 3, 1999, Pages 183-189

  De La Tarodo Fuente, P ^a   Romagnoli, M ^a   Carlsson, L ^a   Godard, P ^a   Bousquet, J ^a   Chanez, P ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; EOSINOPHIL CATIONIC PROTEIN;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; EOSINOPHIL; FOLLOW UP; HUMAN; INFLAMMATION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; SPUTUM;

EID: 0033029579     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(99)90006-9     Document Type: Article

References (37)

1. Dykewicz MS, Greenberger PA, Patterson R, Halwig JM. Natural history of asthma in patients requiring long-term systemic corticosteroids. Arch Intern Med 1986; 146: 2369-2372.
2. Dès-Roches A, Paradis L, Bougeard YH, Godard P, Bousquet J, Chanez P. Long-term oral corticosteroid therapy does not alter the results of immediate-type allergy skin prick tests. J Allergy Clin Immunol 1996; 98: 522-527.
3. Majori M, Vachier I, Godard P, Farce M, Bousquet J, Chanez P. Superoxide anion production by monocytes of corticosteroid-treated asthmatic patients. Eur Respir J 1998; 11: 133-139.
4. Wenzel SE, Szefler SJ, Leung DY, Sloan SI, Rex MD, Martin RJ. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 1997; 156: 737-743.
5. Vachier I, Chiappara G, Vignola A, et al. Glucocorticoid receptors in bronchial epithelial cells in asthma. Am J Respir Crit Care Med 1998; 158: 963-970.
6. Maestrelli P, Saetta M, Di-Stefano A, et al. Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. Am J Respir Crit Care Med \995; 152: 1926-1931.
7. Grootendorst DC, Sont JK, Willems LN, et al. Comparison of inflammatory cell counts in asthma: induced sputum vs bronchoalveolar lavage and bronchial biopsies. Clin Exp Allergy 1997; 27: 769-779.
8. Keatings VM, Evans DJ, O'Connor BJ, Barnes PJ. Cellular profiles in asthmatic airways: a comparison of induced sputum, bronchial washings, and bronchoalveolar lavage fluid. Thorax 1997; 52: 372-374.
9. Hargreave FE. The investigation of airway inflammation in asthma: sputum examination, din Exp Allergy 1997; 1: 36-40.
10. Pin I, Gibson PG, Kolendowicz R, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47: 25-29.
11. Fahy JV, Steiger DJ, Liu J, Basbaum CB, Finkbeiner WE, Boushey HA. Markers of mucus secretion and DNA levels in induced sputum from asthmatic and from healthy subjects. Am Rev Respir Dis 1993; 147: 1132-1137.
12. Iredale MJ, Wanklyn SA, Phillips IP, Krausz T, Ind PW, Non-invasive assessment of bronchial inflammation in asthma: no correlation between eosinophilia of induced sputum and bronchial responsiveness to inhaled hypertonic saline. Clin Exp Allergy 1994; 24: 940-945.
13. Popov TA, Pizzichini MM, Pizzichini E, et al. Some technical factors influencing the induction of sputum for cell analysis. Eur Respir J 1995; 8: 559-565.
14. Fujimoto K, Kubo K, Matsuzawa Y, Sekiguchi M. Eosinophil cationic protein levels in induced sputum correlate with the severity of bronchial asthma. Chest 1997; 112: 1241-1247.
15. Louis R, Shute J, Biagi S, et al. Cell infiltration, ICAM-1 expression, and eosinophil chemotactic activity in asthmatic sputum. Am J Respir Crit Care Med 1997; 155: 466-472.
16. Pizzichini E, Pizzichini MM, Efthimiadis A, Dolovich J, Hargreave FE. Measuring airway inflammation in asthma: eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood. J Allergy Clin Immunol 1997; 99: 539-544.
17. Tarodo de la Fuente P, Romagnoli M, Godard P, Bousquet J, Chanez P. Safety of induced sputum in asthmatics of variable severity. Am J Respir Crit Care Med 1998; 157: 1045-1049.
18. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323: 1033-1039.
19. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144: 1202-1218.
20. WHO/NHLBI workshop report. Global Strategy for Asthma Management and Prevention. National Institutes of Health, National Heart, Lung and Blood Institute, Publication Number 95-3659, 1995.
21. Counil FP, Lebel B, Segondy M, et al. Cells and mediators from pharyngeal secretions in infants with acute wheezing episodes. Eur Respir J 1997; 10: 25912595.
22. Foresi A, Leone C, Pelucchi A, et al. Eosinophils, mast cells, and basophils in induced sputum from patients with seasonal allergic rhinitis and perennial asthma: relationship to methacholine responsiveness. / Allergy Clin Immunol 1997; 100: 58-64.
23. Kidney JC, Wong AG, Efthimiadis A, et al. Elevated B cells in sputum of asthmatics. Close correlation with eosinophils. Am J Respir Crit Care Med 1996; 153: 540-544.
24. Ronchi MC, Piragino C, Rosi E, et al. Do sputum eosinophils and ECP relate to the severity of asthma? Eur Respir J 1997; 10: 1809-1813.
25. Motojima S, Akutsu I, Fukuda T, Makino S, Takatsu K. Clinical significance of measuring levels of sputum and serum ECP and serum IL-5 in bronchial asthma. Allergy 1993; 48: 98-106.
26. Hansel TT, Braunstein JB, Walker C, et al. Sputum eosinophils from asthmatics express ICAM-1 and HLA-DR. Clin Exp Immunol 1991; 86: 271-277.
27. Virchow J Jr, Holscher U, Virchow C Sr. Sputum ECP levels correlate with parameters of airflow obstruction. Am Rev Respir Dis 1992; 146: 604-606.
28. Virchow J Jr, Kroegel C, Hage U, Kortsik C, Matthys H, Werner P. Comparison of sputum-ECP levels in bronchial asthma and chronic bronchitis. Allergy 1993; 48: 112-118.
29. Spanevello A, Beghe B, Bianchi A, et al. Comparison of two methods of processing induced sputum: selected versus entire sputum. Am J Respir Crit Care Med 1998; 157: 665-668.
30. Adelroth E, Rosenhall L, Johansson SA, Linden M, Venge P. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline. Am Rev Respir Dis 1990; 142: 91-99.
31. Jeffery PK, Godfrey RW, Adelroth E, Nelson F, Rogers A, Johansson SA. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. Am Rev Respir Dis 1992; 145: 890-899.
32. Keatings VM, Barnes PJ. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med 1997; 155: 449-453.
33. Vignola AM, Bonanno A, Mirabella A, et al. Increased levels of elastase and alpha 1-antitrypsin in sputum of asthmatic patients. Am J Respir Crit Care Med 1998; 157:505-511.
34. Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled forraoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997; 337: 1405-1411.
35. Laitinen LA, Laitinen A, Heino M, Haahtela T. Eosinophilic airway inflammation during exacerbation of asthma and its treatment with inhaled corticosteroid. Am Rev Respir Dis 1991; 143: 423-427.
36. Fahy JV, Kirn KW, Liu J, Boushey HA. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995; 95: 843-852.
37. Pizzichini MM, Pizzichini E, Clelland L, et al. Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment. Am J Respir Cut Care Med 1997; 155: 1501-1508.